CytoDyn Settles Investor Suit With $500K, 49M Shares
By Rachel Riley · March 20, 2026, 10:20 PM EDT
Biotechnology firm CytoDyn has agreed to dole out 49 million shares of common stock and pay $500,000 to end investors' proposed class action accusing the company of overstating the likelihood that...
To view the full article, register now.